B. Jensen

发表

H. Stellbrink, E. Olliges, B. Bührlen, 2021, AIDS care.

Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)

J. van Lunzen, M. Addo, J. Rockstroh, 2019, AIDS Research and Therapy.

Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study

A. Zoufaly, N. Taylor, A. Schultze, 2018, Haematologica.

Ambulatory care for HIV-infected patients: differences in outcomes between hospital-based units and private practices: analysis of the RESINA cohort

Thomas Lengauer, R. Kaiser, D. Häussinger, 2013, European Journal of Medical Research.

Parameters Influencing Baseline HIV-1 Genotypic Tropism Testing Related to Clinical Outcome in Patients on Maraviroc

Thomas Lengauer, R. Kaiser, D. Hoffmann, 2015, PloS one.

Multicentric Castleman’s disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018

T. Luedde, B. Jensen, H. Orth, 2021, Infection.

Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patients

R. Kaiser, D. Häussinger, A. De Luca, 2021, Infection.

HIV-1 Subtype Diversity and Prevalence of Primary Drug Resistance in a Single-Center Pediatric Cohort in Germany

A. Borkhardt, B. Jensen, H. Laws, 2017, Intervirology.

HIV-2: A summary of present standard of care and treatment options for HIV-2 infected individuals living in Western Europe.

C. Charpentier, R. Kaiser, J. Rockstroh, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human Immunodeficiency Virus–2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe

C. Charpentier, R. Kaiser, J. Rockstroh, 2020, Clinical Infectious Diseases.

Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients

J. van Lunzen, B. Jensen, G. Fätkenheuer, 2012, AIDS.

Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany

Michael J. Rausch, H. Jessen, M. Bickel, 2022, HIV medicine.

Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany

H. Stellbrink, E. Schülter, B. Jensen, 2014, PloS one.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Survival of AIDS‐related diffuse large B‐cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort

A. Zoufaly, B. Jensen, P. Schommers, 2015, British journal of haematology.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1

N. Kröger, J. Martinez-Picado, J. van Lunzen, 2020, Science Translational Medicine.

CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care—a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999–2013

J. van Lunzen, H. Stellbrink, J. Rockstroh, 2016, BMC Infectious Diseases.

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany

J. van Lunzen, H. Stellbrink, J. Rockstroh, 2015, BMC Public Health.

Proviral DNA as a Target for HIV-1 Resistance Analysis

Thomas Lengauer, R. Kaiser, E. Schülter, 2015, Intervirology.

Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study

H. Jessen, H. Stellbrink, M. Bickel, 2020, Open forum infectious diseases.

Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning

R. König, M. Oswald, J. Nattermann, 2021, Infection.

Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitors.

H. Walter, R. Kaiser, B. Jensen, 2016, Journal of virological methods.

Changes in the HIV‐1 mutational profile before first‐line HAART in the RESINA cohort

R. Kaiser, D. Häussinger, B. Jensen, 2011, Journal of medical virology.

Maraviroc in treatment-experienced patients with HIV-1 infection - experience from routine clinical practice

R. Kaiser, D. Häussinger, B. Jensen, 2010, European journal of medical research.

Using drug exposure for predicting drug resistance – A data-driven genotypic interpretation tool

Thomas Lengauer, Hauke Walter, Rolf Kaiser, 2017, PloS one.

AIDS in the era of antiretroviral therapy: Changes in incidence rates and predictors of AIDS among people living with HIV under clinical care in Germany, a cohort study 1999–2018

B. Jensen, C. Stephan, V. Bremer, 2023, HIV medicine.

Switching to a NRTI-free 2 drug regimen (2DR) –a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes

H. Jessen, H. Stellbrink, C. Boesecke, 2022, HIV Research & Clinical Practice.

Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017

H. Stellbrink, C. Boesecke, B. Jensen, 2020, Infection.

Failure of Dolutegravir First-Line ART with Selection of Virus Carrying R263K and G118R.

Thomas Lengauer, R. Kaiser, M. Däumer, 2019, The New England journal of medicine.